4IRV | pdb_00004irv

Structure of the Helicobacter pylori CagA Oncogene Bound to the Human Tumor Suppressor Apoptosis-stimulating Protein of p53-2

External Resource: Annotation

Domain Annotation: ECOD Classification
Domain Annotation: CATH
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
D	EUF08079	e4irvD1	A: alpha bundles	X: Oncogenic effector CagA N-terminal domain (From Topology)	H: Oncogenic effector CagA N-terminal domain (From Topology)	T: Oncogenic effector CagA N-terminal domain	F: EUF08079	ECOD (1.6)
C	EUF08079	e4irvC1	A: alpha bundles	X: Oncogenic effector CagA N-terminal domain (From Topology)	H: Oncogenic effector CagA N-terminal domain (From Topology)	T: Oncogenic effector CagA N-terminal domain	F: EUF08079	ECOD (1.6)
B	EUF08079	e4irvB1	A: alpha bundles	X: Oncogenic effector CagA N-terminal domain (From Topology)	H: Oncogenic effector CagA N-terminal domain (From Topology)	T: Oncogenic effector CagA N-terminal domain	F: EUF08079	ECOD (1.6)
A	EUF08079	e4irvA1	A: alpha bundles	X: Oncogenic effector CagA N-terminal domain (From Topology)	H: Oncogenic effector CagA N-terminal domain (From Topology)	T: Oncogenic effector CagA N-terminal domain	F: EUF08079	ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
D	1.10.357.130	Mainly Alpha	Orthogonal Bundle	Tetracycline Repressor	domain 2	CATH (4.3.0)
C	1.10.357.130	Mainly Alpha	Orthogonal Bundle	Tetracycline Repressor	domain 2	CATH (4.3.0)
B	1.10.357.130	Mainly Alpha	Orthogonal Bundle	Tetracycline Repressor	domain 2	CATH (4.3.0)
A	1.10.357.130	Mainly Alpha	Orthogonal Bundle	Tetracycline Repressor	domain 2	CATH (4.3.0)

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B, C, D	Cytotoxicity-associated immunodominant antigen	toxin transmembrane transporter activity transporter activity transmembrane transporter activity molecular adaptor activity	symbiont-mediated perturbation of host cellular process biological process involved in interspecies interaction between organisms symbiont-mediated perturbation of host process symbiont-mediated perturbation of host cell cycle progression modulation of process of another organism biological process involved in interaction with host biological process involved in symbiotic interaction	-
E, F, G, H	Apoptosis-stimulating of p53 protein 2	p53 binding protein binding binding SH3 domain binding protein domain specific binding transcription factor binding RNA polymerase II-specific DNA-binding transcription factor binding DNA-binding transcription factor binding NF-kappaB binding identical protein binding protein homodimerization activity protein dimerization activity	cellular response to stimulus regulation of biological process regulation of cellular process response to stimulus signaling biological regulation signal transduction by p53 class mediator cell death intracellular signal transduction cell communication apoptotic signaling pathway intrinsic apoptotic signaling pathway by p53 class mediator cellular process signal transduction cellular response to stimulus regulation of biological process regulation of cellular process response to stimulus signaling biological regulation signal transduction by p53 class mediator cell death intracellular signal transduction cell communication apoptotic signaling pathway intrinsic apoptotic signaling pathway by p53 class mediator cellular process signal transduction apoptotic process intrinsic apoptotic signaling pathway programmed cell death negative regulation of cellular process negative regulation of biological process negative regulation of cell cycle cell cycle regulation of cell cycle positive regulation of programmed cell death regulation of apoptotic process positive regulation of biological process regulation of programmed cell death positive regulation of apoptotic process regulation of execution phase of apoptosis positive regulation of execution phase of apoptosis execution phase of apoptosis positive regulation of cellular process	cellular anatomical structure cell junction intracellular anatomical structure cytoplasm cytosol perinuclear region of cytoplasm membrane-bounded organelle nucleus membrane-enclosed lumen intracellular membrane-bounded organelle intracellular organelle lumen intracellular organelle nucleoplasm organelle lumen cellular anatomical structure cell junction intracellular anatomical structure cytoplasm cytosol perinuclear region of cytoplasm membrane-bounded organelle nucleus membrane-enclosed lumen intracellular membrane-bounded organelle intracellular organelle lumen intracellular organelle nucleoplasm organelle lumen organelle nuclear lumen

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B, C, D	IPR045157	CagA, N-terminal	Domain
A, B, C, D	IPR005169	CagA exotoxin, phosphopeptide substrate mimic region	Domain
A, B, C, D	IPR004355	Type IV secretion system CagA exotoxin	Family
E, F, G, H	IPR002110	Ankyrin repeat	Repeat
E, F, G, H	IPR036770	Ankyrin repeat-containing domain superfamily	Homologous Superfamily
E, F, G, H	IPR047163	Apoptosis-stimulating of p53 protein 1/2	Family
E, F, G, H	IPR047166	Apoptosis-stimulating protein of p53 protein 2, RA domain	Domain
E, F, G, H	IPR001452	SH3 domain	Domain
E, F, G, H	IPR048942	Apoptosis-stimulating of p53 protein 2-like, RA domain	Domain
E, F, G, H	IPR036028	SH3-like domain superfamily	Homologous Superfamily
E, F, G, H	IPR029071	Ubiquitin-like domain superfamily	Homologous Superfamily

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
E, F, G, H	Pharos: Q13625	Neoplasm Invasiveness invasive lobular breast carcinoma breast carcinoma acute myeloid leukemia Down syndrome breast cancer osteosarcoma medulloblastoma ovarian cancer

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.